vs
康美（CNMD）与OMNICELL, INC.（OMCL）财务数据对比。点击上方公司名可切换其他公司
康美的季度营收约是OMNICELL, INC.的1.2倍（$373.2M vs $309.9M），OMNICELL, INC.同比增速更快（14.9% vs 7.9%），康美自由现金流更多（$41.2M vs $38.6M），过去两年康美的营收复合增速更高（9.3% vs 5.8%）
康美公司是一家上市的美国医疗设备制造商，主营骨科、腹腔镜、普通外科相关医疗器械以及各类患者护理产品，总部现位于佛罗里达州拉戈，2022年7月前设于纽约州尤蒂卡。该品牌秉持以人为本的文化，以助力医疗合作方及其服务的患者为核心使命，在美国和墨西哥都设有生产基地。
Omnicell是总部位于美国加州山景城的跨国医疗科技企业，专注于为医院及各类医疗机构提供药品管理自动化系统，同时面向零售药房推出用药依从性包装与患者互动软件，旗下产品使用Omnicell及EnlivenHealth两大品牌。
CNMD vs OMCL — 直观对比
营收规模更大
CNMD
是对方的1.2倍
$309.9M
营收增速更快
OMCL
高出7.0%
7.9%
自由现金流更多
CNMD
多$2.6M
$38.6M
两年增速更快
CNMD
近两年复合增速
5.8%
损益表 — Q4 FY2025 vs Q1 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $373.2M | $309.9M |
| 净利润 | — | $11.4M |
| 毛利率 | 58.5% | 45.3% |
| 营业利润率 | 9.8% | — |
| 净利率 | — | 3.7% |
| 营收同比 | 7.9% | 14.9% |
| 净利润同比 | — | 261.7% |
| 每股收益（稀释后） | $0.54 | $0.25 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CNMDOMCL
| Q1 26 | — | $309.9M | ||
| Q4 25 | $373.2M | $314.0M | ||
| Q3 25 | $337.9M | $310.6M | ||
| Q2 25 | $342.3M | $290.6M | ||
| Q1 25 | $321.3M | $269.7M | ||
| Q4 24 | $345.9M | $306.9M | ||
| Q3 24 | $316.7M | $282.4M | ||
| Q2 24 | $332.1M | $276.8M |
净利润CNMDOMCL
| Q1 26 | — | $11.4M | ||
| Q4 25 | — | — | ||
| Q3 25 | $2.9M | $5.5M | ||
| Q2 25 | $21.4M | $5.6M | ||
| Q1 25 | $6.0M | $-7.0M | ||
| Q4 24 | — | — | ||
| Q3 24 | $49.0M | $8.6M | ||
| Q2 24 | $30.0M | $3.7M |
毛利率CNMDOMCL
| Q1 26 | — | 45.3% | ||
| Q4 25 | 58.5% | 41.5% | ||
| Q3 25 | 49.2% | 43.3% | ||
| Q2 25 | 55.0% | 43.9% | ||
| Q1 25 | 55.3% | 41.1% | ||
| Q4 24 | 57.3% | 46.2% | ||
| Q3 24 | 56.5% | 43.3% | ||
| Q2 24 | 55.3% | 41.3% |
营业利润率CNMDOMCL
| Q1 26 | — | — | ||
| Q4 25 | 9.8% | 0.1% | ||
| Q3 25 | 3.5% | 2.7% | ||
| Q2 25 | 11.1% | 2.8% | ||
| Q1 25 | 5.0% | -4.3% | ||
| Q4 24 | 15.2% | 4.0% | ||
| Q3 24 | 20.7% | 2.3% | ||
| Q2 24 | 14.2% | 1.2% |
净利率CNMDOMCL
| Q1 26 | — | 3.7% | ||
| Q4 25 | — | — | ||
| Q3 25 | 0.8% | 1.8% | ||
| Q2 25 | 6.3% | 1.9% | ||
| Q1 25 | 1.9% | -2.6% | ||
| Q4 24 | — | — | ||
| Q3 24 | 15.5% | 3.1% | ||
| Q2 24 | 9.0% | 1.3% |
每股收益（稀释后）CNMDOMCL
| Q1 26 | — | $0.25 | ||
| Q4 25 | $0.54 | $-0.05 | ||
| Q3 25 | $0.09 | $0.12 | ||
| Q2 25 | $0.69 | $0.12 | ||
| Q1 25 | $0.19 | $-0.15 | ||
| Q4 24 | $1.09 | $0.34 | ||
| Q3 24 | $1.57 | $0.19 | ||
| Q2 24 | $0.96 | $0.08 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | — | $239.2M |
| 总债务越低越好 | $834.2M | — |
| 股东权益账面价值 | $1.0B | $1.3B |
| 总资产 | $2.3B | $2.0B |
| 负债/权益比越低杠杆越低 | 0.81× | — |
8季度趋势，按日历期对齐
现金及短期投资CNMDOMCL
| Q1 26 | — | $239.2M | ||
| Q4 25 | — | $196.5M | ||
| Q3 25 | — | $180.1M | ||
| Q2 25 | — | $399.0M | ||
| Q1 25 | — | $386.8M | ||
| Q4 24 | — | $369.2M | ||
| Q3 24 | — | $570.6M | ||
| Q2 24 | — | $556.8M |
总债务CNMDOMCL
| Q1 26 | — | — | ||
| Q4 25 | $834.2M | — | ||
| Q3 25 | $853.0M | — | ||
| Q2 25 | $881.1M | — | ||
| Q1 25 | $891.4M | — | ||
| Q4 24 | $905.1M | — | ||
| Q3 24 | $940.1M | — | ||
| Q2 24 | $965.2M | — |
股东权益CNMDOMCL
| Q1 26 | — | $1.3B | ||
| Q4 25 | $1.0B | $1.2B | ||
| Q3 25 | $1.0B | $1.2B | ||
| Q2 25 | $1.0B | $1.3B | ||
| Q1 25 | $977.6M | $1.3B | ||
| Q4 24 | $962.7M | $1.2B | ||
| Q3 24 | $932.9M | $1.2B | ||
| Q2 24 | $881.8M | $1.2B |
总资产CNMDOMCL
| Q1 26 | — | $2.0B | ||
| Q4 25 | $2.3B | $2.0B | ||
| Q3 25 | $2.3B | $1.9B | ||
| Q2 25 | $2.3B | $2.1B | ||
| Q1 25 | $2.3B | $2.2B | ||
| Q4 24 | $2.3B | $2.1B | ||
| Q3 24 | $2.3B | $2.3B | ||
| Q2 24 | $2.3B | $2.3B |
负债/权益比CNMDOMCL
| Q1 26 | — | — | ||
| Q4 25 | 0.81× | — | ||
| Q3 25 | 0.85× | — | ||
| Q2 25 | 0.88× | — | ||
| Q1 25 | 0.91× | — | ||
| Q4 24 | 0.94× | — | ||
| Q3 24 | 1.01× | — | ||
| Q2 24 | 1.09× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $46.3M | $54.5M |
| 自由现金流经营现金流 - 资本支出 | $41.2M | $38.6M |
| 自由现金流率自由现金流/营收 | 11.0% | 12.5% |
| 资本支出强度资本支出/营收 | 1.4% | — |
| 现金转化率经营现金流/净利润 | — | 4.80× |
| 过去12个月自由现金流最近4个季度 | $150.9M | $110.8M |
8季度趋势，按日历期对齐
经营现金流CNMDOMCL
| Q1 26 | — | $54.5M | ||
| Q4 25 | $46.3M | $30.4M | ||
| Q3 25 | $53.7M | $28.3M | ||
| Q2 25 | $29.1M | $42.8M | ||
| Q1 25 | $41.5M | $25.9M | ||
| Q4 24 | $43.3M | $56.3M | ||
| Q3 24 | $51.2M | $22.8M | ||
| Q2 24 | $43.3M | $58.7M |
自由现金流CNMDOMCL
| Q1 26 | — | $38.6M | ||
| Q4 25 | $41.2M | $22.6M | ||
| Q3 25 | $48.5M | $18.5M | ||
| Q2 25 | $23.4M | $31.0M | ||
| Q1 25 | $37.8M | $14.8M | ||
| Q4 24 | $39.3M | $47.2M | ||
| Q3 24 | $47.8M | $13.9M | ||
| Q2 24 | $39.7M | $49.1M |
自由现金流率CNMDOMCL
| Q1 26 | — | 12.5% | ||
| Q4 25 | 11.0% | 7.2% | ||
| Q3 25 | 14.4% | 6.0% | ||
| Q2 25 | 6.8% | 10.7% | ||
| Q1 25 | 11.8% | 5.5% | ||
| Q4 24 | 11.4% | 15.4% | ||
| Q3 24 | 15.1% | 4.9% | ||
| Q2 24 | 12.0% | 17.8% |
资本支出强度CNMDOMCL
| Q1 26 | — | — | ||
| Q4 25 | 1.4% | 2.5% | ||
| Q3 25 | 1.5% | 3.1% | ||
| Q2 25 | 1.7% | 4.1% | ||
| Q1 25 | 1.2% | 4.1% | ||
| Q4 24 | 1.2% | 3.0% | ||
| Q3 24 | 1.1% | 3.1% | ||
| Q2 24 | 1.1% | 3.5% |
现金转化率CNMDOMCL
| Q1 26 | — | 4.80× | ||
| Q4 25 | — | — | ||
| Q3 25 | 18.78× | 5.18× | ||
| Q2 25 | 1.36× | 7.58× | ||
| Q1 25 | 6.88× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 1.05× | 2.64× | ||
| Q2 24 | 1.44× | 15.72× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CNMD
| Transferred At Point In Time | $358.5M | 96% |
| Transferred Over Time | $14.7M | 4% |
OMCL
| Product revenues | $174.8M | 56% |
| Service revenues | $135.1M | 44% |
